Cite
HARVARD Citation
Loughrey, B. et al. (n.d.). Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low‐dose atorvastatin treatment: evidence from a randomized controlled trial. Clinical endocrinology. pp. 800-806. [Online].